Exercise rehabilitation in heart disease: The real "polypill" for primary and secondary prevention

Monaldi Archives for Chest Disease - Cardiac Series

Volumn 64, Issue 2, 2005, Pages 88-93

  Piepoli, Massimo F ^a  

^a GUGLIELMO DA SALICETO HOSPITAL   (Italy)

Author keywords

Conditioning; Exercise; Prevention

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOLIC ACID; HOMOCYSTEINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; PLACEBO; THIAZIDE DIURETIC AGENT;

AEROBIC EXERCISE; BEHAVIOR MODIFICATION; BLEEDING; CARDIOVASCULAR RISK; CHOLESTEROL DIET; CIGARETTE SMOKING; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DIET THERAPY; DISEASE SEVERITY; DOSE RESPONSE; DRUG CONTRAINDICATION; DRUG FORMULATION; EDITORIAL; EXERCISE TOLERANCE; GENETIC PREDISPOSITION; GLUCOSE BLOOD LEVEL; HEALTH CARE COST; HEART DISEASE; HEART MUSCLE REVASCULARIZATION; HEART REHABILITATION; HUMAN; HYPERTENSION; INCIDENCE; LIFESTYLE; MEDICAL RESEARCH; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; PRIMARY PREVENTION; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SECONDARY PREVENTION; STATISTICAL SIGNIFICANCE; SURVIVAL; TREADMILL EXERCISE; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 32644457273     PISSN: 11220643     EISSN: None     Source Type: Journal    
DOI: 10.4081/monaldi.2005.592     Document Type: Editorial

References (31)

1. Dorland's Illustrated Medical Dictionary (25th ed.). Philadel-phia, PA: Saunders, 1974.
2. Hoffman C, Rice D, Sung H-Y. Persons with chronic conditions. JAMA 1996; 276: 1473-1479.
3. Booth FW, Chakravarthy MV, Gordon SE, Spangenburg EE. Waging war on physical inactivity: using modern molecular ammunition against an ancient enemy. J Appl Physiol 2001; 93: 3-30.
4. Cordain L, Gotshall RW, Eaton SB, and Eaton SB III. Physical activity, energy expenditure and fitness: an evolutionary perspective. Int J Sports Med 1998; 19: 328-335.
5. Eaton SB, Konner M, and Shostak M. Stone agers in the fast lane: chronic degenerative diseases in evolutionary perspective. Am J Med 1988; 84: 739-749.
6. Spirduso WW, Cronin DL. Exercise dose-response effects on quality of life and independent living in older adults. Med Sci Sports Exerc 2001; 33: S598-S610.
7. Bonow RO, Smaha LA, Smith SC Jr, Mensah GA, Lenfant C. The international burden of cardiovascular disease: responding to the emerging global epidemic. Circulation 2002; 106: 1602-1605.
8. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ 2003; 326: 1419-1423.
9. Rodgers A. A cure for cardiovascular disease? BMJ 2003; 326: 1407-1408.
10. Law MR, Wald NJ. Risk factor thresholds: their existence under scrutiny. BMJ 2002; 324: 1570-1576.
11. Eidelman RS, Hebert PR, Weisman SM, Hennekens CH. An update on aspirin in the primary prevention of cardiovascular disease. Arch Intern Med 2003; 163: 2006-2010.
12. Pearson TA, Blair SN, Daniels SR, Eckel RH, Fair JM, Fortmann SP, Franklin BA, Goldstein LB, Greenland P, Grundy SM, et al. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update. Consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. Circulation 2002; 106: 388-391.
13. Booth FW, Gordon SE, Carlson CJ, Hamilton MT, Waging war on modern chronic diseases: primary prevention through exercise biology. J Appl Physiol 2000; 88: 774-787.
14. Hennekens CH, Increasing burden of cardiovascular disease: current knowledge and future directions for research on risk factors. Circulation 1998; 97: 1095-1102.
15. NCEP Expert Panel, Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
16. Williams PT. Physical fitness and activity as separate heart disease risk factors: a meta-analysis. Med Sci Sports Exerc 2001; 33: 754-761.
17. Powell KE, Thompson PD, Caspersen CJ, Kendrick JS. Physical activity and the incidence of coronary heart disease. Annu Rev Public Health 1987; 8: 253-287.
18. Roberts WC. An agent with lipid-lowering, antihypertensive, positive inotropic, negative chronotropic, vasodilating, diuretic, anorexigenic, weight-reducing, cathartic, hypoglycemic, tranquilizing, hypnotic and antidepressive qualities. Am J Cardiol 1984; 53: 261-262.
19. Hambrecht R, Walther C, Möbius-Winkler S, Gielen S, Linke A, Conradi K, Erbs S, Kluge R, Kendziorra K, Sabri O, Sick P, Schuler G. Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease. A randomized trial. Circulation 2004; 109: 1371-1378.
20. Thompson PD, Buchner D, Piña IL, Balady GJ, Williams MA, Marcus BH, Berra K, Blair SN, Costa F, Franklin B, et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease. Circulation 2003; 107: 3109-3116.
21. Dunn AL, Marcus BH, Kampert JB, Garcia ME, Kohl HW III, Blair SN. Comparison of lifestyle and structured interventions to increase physical activity and cardiorespiratory fitness: a randomized trial. JAMA 1999; 281: 327-334.
22. Franklin BA, de Jong A, Kahn JK, McCullough PA. Fitness and mortality in the primary and secondary prevention of coronary artery disease: does the effort justify the outcome? Am J Med Sports 2004; 6: 23-27.
23. Barnard RJ, Di Lauro SC, Inkeles SB. Effects of intensive diet and exercise intervention in patients taking cholesterol-lowering drugs. Am J Cardiol 1997; 79: 1112-1114.
24. Prochaska J, Di Clemente C. Transtheoretical therapy, toward a more integrative model of change. Psych Theory Res Prac 1982; 19: 276-288.
25. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 1997; 336: 1117-1124.
26. Writing Group of the PREMIER Collaborative Research Group. Effects of comprehensive lifestyle modification on blood pressure control. JAMA 2003; 289: 2083-2093.
27. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne - Parikka P, Keinäen-Kiukaanniemi S, Laaksso M, Louheranta A, Rastas M, Salminen V, Uusitupa M, for the Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-1350.
28. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, for the Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
29. Coats AJ, Adamopoulos S, Meyer TE, Conway J, Sleight P. Effects of physical training in chronic heart failure. Lancet 1990; 335 (8681): 63-6.
30. Belardinelli R, Georgiou D, Ginzton L, Cianci G, Purcaro A. Effects of moderate exercise training on thallium uptake and contractile response to low-dose dobutamine of dysfunctional myocardium in patients with ischemic cardiomyopathy. Circulation 1998; 97 (6): 553-61.
31. Piepoli MF, Davos C, Francis DP, Coats AJ, ExTra-MATCH Collaborative. Exercise training meta-analysis of trials in patients with chronic heart failure (ExTra-MATCH). BMJ 2004; 328 (7433): 1.